LONSURF 20/8.19 MG 20 F.C. TABS

LONSURF is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine a platinum either a taxane or irinotecan and if appropriate HER2/neu-targeted therapy.